These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15028411)

  • 1. Re: Dosimetric consequences of increased seed strength for I-125 prostate implants. Radiother Oncol. 2003 Sep;68(3):295-7.
    Lee WR
    Radiother Oncol; 2004 Feb; 70(2):209-10; author reply 210. PubMed ID: 15028411
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Albertsen PC
    J Urol; 2005 Nov; 174(5):1969-70. PubMed ID: 16217368
    [No Abstract]   [Full Text] [Related]  

  • 3. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
    W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Lee WR
    Urology; 2010 Jun; 75(6):1416-7; author reply 1417. PubMed ID: 20513503
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of random seed placement error in permanent transperineal prostate seed implant.
    Bues M; Holupka EJ; Meskell P; Kaplan ID
    Radiother Oncol; 2006 Apr; 79(1):70-4. PubMed ID: 16515813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity].
    Pommier P; Delannes M; LeFloch O; Bernier V; Baron MH; Thomas L; Malet C; Bonnet J; Louisot P; Aletti P; Goubard O; Chemin A; Chirat F; Lebivic S; Montbarbon X; Bachaud JM; Votron L; Lasbareilles O; Desmettre O; Bringeon G; Gassa F; Peiffert D
    Cancer Radiother; 2006 Dec; 10(8):559-64. PubMed ID: 16959520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 125I dosimetry in prostatic brachytherapy planning.
    Piermattei A
    Rays; 1993; 18(1):58-62. PubMed ID: 8356241
    [No Abstract]   [Full Text] [Related]  

  • 10. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterpoint: there is a dose-response relationship in the low-dose rate brachytherapy management of prostate cancer.
    Stock RG
    Brachytherapy; 2010; 9(4):293-6; discussion 299. PubMed ID: 20833593
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: new radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Sterotactic radiotherapy? Intensity modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy? Or nothing at all? [Radiother Oncol 2004;71(3):247-249].
    Bauman GS; Wong E
    Radiother Oncol; 2004 Nov; 73(2):251-2. PubMed ID: 15542173
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brachytherapy for prostate cancer].
    Yorozu A; Toya K; Ohashi T; Ohsuga K; Ito R; Kasamatsu T; Saito S; Momma T
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):424-7. PubMed ID: 16612148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD; Thames HD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point: the relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: is there an elephant in the room?
    Morris WJ; Halperin R; Spadinger I
    Brachytherapy; 2010; 9(4):289-92; discussion 297-8. PubMed ID: 20739226
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosimetric consequences of increased seed strength for I-125 prostate implants.
    Sloboda RS; Pedersen JE; Hanson J; Halperin RM
    Radiother Oncol; 2003 Sep; 68(3):295-7. PubMed ID: 13129638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on Moerland et al. study of decline of dose coverage between different implant techniques for I125 prostate brachytherapy.
    Al-Qaisieh B
    Radiother Oncol; 2010 Mar; 94(3):386-7; author reply 386. PubMed ID: 20207039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.